Opthea Limited American Depositary Shares
OPT
OPT was delisted on the 17th of March, 2025.
0 hedge funds and large institutions have $0 invested in Opthea Limited American Depositary Shares in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 6 closing their positions.
100% less funds holding
Funds holding: 6 → 0 (-6)
100% less capital invested
Capital invested by funds: $64.2K → $0 (-$64.2K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$61.6K |
| 2 |
Morgan Stanley
New York
|
-$2.57K |
| 3 |
HSBC Holdings
London,
United Kingdom
|
-$10 |
OPT Hedge Fund Activity: Q4 2025 in Review
0 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Opthea Limited American Depositary Shares (OPT) for Q4 2025, worth a combined $0 — down 100% from $64.2K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of OPT and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $61.6K sold.
- 0 institutional investors held Opthea Limited American Depositary Shares (OPT) as of Q4 2025, down from 6 in Q3 2025.
- Funds reported $0 of Opthea Limited American Depositary Shares stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new Opthea Limited American Depositary Shares positions in Q4 2025 and 6 closed out, a net change of -6 holders.
- The largest Opthea Limited American Depositary Shares seller in Q4 2025 was UBS Group, an estimated $61.6K sold.
Based on aggregated 13F filings for Q4 2025.